BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27855647)

  • 1. Albuminuria, serum antioxidant enzyme levels and markers of hemolysis and inflammation in steady state children with sickle cell anemia.
    Itokua KE; Makulo JR; Lepira FB; Aloni MN; Ekulu PM; Sumaili EK; Bukabau JB; Mokoli VM; Longo AL; Kajingulu FM; Zinga CV; Nlandu YM; Engole YM; Akilimali PZ; Ngiyulu RM; Gini JL; Nseka NM
    BMC Nephrol; 2016 Nov; 17(1):178. PubMed ID: 27855647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Fas/FasL ratio as a marker of vasculopathy in children and adolescents with sickle cell disease.
    Adly AA; Ismail EA; Andrawes NG; Mahmoud MM; Eladawy R
    Cytokine; 2016 Mar; 79():52-8. PubMed ID: 26765484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia.
    Aleluia MM; da Guarda CC; Santiago RP; Fonseca TC; Neves FI; de Souza RQ; Farias LA; Pimenta FA; Fiuza LM; Pitanga TN; Ferreira JR; Adorno EV; Cerqueira BA; Gonçalves MS
    Lipids Health Dis; 2017 Apr; 16(1):74. PubMed ID: 28399852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia.
    Hamideh D; Raj V; Harrington T; Li H; Margolles E; Amole F; Garcia-Buitrago M; Ruiz P; Zilleruelo G; Alvarez O
    Pediatr Nephrol; 2014 Oct; 29(10):1997-2003. PubMed ID: 24890337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia.
    Gurkan S; Scarponi KJ; Hotchkiss H; Savage B; Drachtman R
    Pediatr Nephrol; 2010 Oct; 25(10):2123-7. PubMed ID: 20517617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher rates of hemolysis are not associated with albuminuria in Jamaicans with sickle cell disease.
    Asnani MR; Fraser RA; Reid ME
    PLoS One; 2011 Apr; 6(4):e18863. PubMed ID: 21533141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for interactions between inflammatory markers and renin-angiotensin system molecules in the occurrence of albuminuria in children with sickle cell anemia.
    Belisário AR; Vieira ÉLM; de Almeida JA; Mendes FG; Miranda AS; Rezende PV; Viana MB; Simões E Silva AC
    Cytokine; 2020 Jan; 125():154800. PubMed ID: 31442679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic and eicosapentaenoic acid supplementation does not exacerbate oxidative stress or intravascular haemolysis in homozygous sickle cell patients.
    Daak AA; Ghebremeskel K; Mariniello K; Attallah B; Clough P; Elbashir MI
    Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):305-11. PubMed ID: 24095588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential utility of melatonin as an antioxidant therapy in the management of sickle cell anemia.
    da Silva DG; Ricci O; de Almeida EA; Bonini-Domingos CR
    J Pineal Res; 2015 Mar; 58(2):178-88. PubMed ID: 25545035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered HDL particle in sickle cell disease: decreased cholesterol content is associated with hemolysis, whereas decreased Apolipoprotein A1 is linked to inflammation.
    Yalcinkaya A; Unal S; Oztas Y
    Lipids Health Dis; 2019 Dec; 18(1):225. PubMed ID: 31861992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with sickle cell disease have reduced blood antioxidant protection.
    Ren H; Ghebremeskel K; Okpala I; Lee A; Ibegbulam O; Crawford M
    Int J Vitam Nutr Res; 2008 May; 78(3):139-47. PubMed ID: 19003736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enalapril and hydroxyurea therapy for children with sickle nephropathy.
    Fitzhugh CD; Wigfall DR; Ware RE
    Pediatr Blood Cancer; 2005 Dec; 45(7):982-5. PubMed ID: 15704213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1).
    Youssry I; Makar S; Fawzy R; Wilson M; AbdAllah G; Fathy E; Sawires H
    Pediatr Nephrol; 2015 Dec; 30(12):2163-8. PubMed ID: 26238275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of albuminuria in sickle cell disease patients at the Campus university hospital of Lome, Togo].
    Layibo Y; Kuéviakoé IM; Padaro E; Magnang H; Vovor A; Agbonon A
    Ann Biol Clin (Paris); 2019 Feb; 77(1):79-86. PubMed ID: 30799301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Nitric Oxide Synthase (eNOS) Gene Polymorphisms and Markers of Hemolysis, Inflammation and Endothelial Dysfunction in Brazilian Sickle Cell Anemia Patients.
    Chenou F; Albuquerque DM; Leonardo DP; Domingos IF; Bezerra MAC; Araújo AS; Blotta MHSL; Costa FF; Sonati MF; Paula EV; Santos MNN
    Biochem Genet; 2020 Aug; 58(4):580-594. PubMed ID: 32277314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure.
    Guasch A; Navarrete J; Nass K; Zayas CF
    J Am Soc Nephrol; 2006 Aug; 17(8):2228-35. PubMed ID: 16837635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-albuminuria in Ugandan children with sickle cell anaemia: a cross-sectional study.
    Mawanda M; Ssenkusu JM; Odiit A; Kiguli S; Muyingo A; Ndugwa C
    Ann Trop Paediatr; 2011; 31(2):115-21. PubMed ID: 21575315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.
    Elbarbary NS; Ismail EA; Roushdy A; Fahmy E
    Blood Cells Mol Dis; 2016 Mar; 57():1-7. PubMed ID: 26852648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
    Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
    Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.